Andreia Santos-Lima, CEO of ImageCare Radiology, hopes the campaign will emphasize the need for preventive measures. She says, “Our campaign acts as a reminder that women’s health cannot be put on hold. Having an annual mammogram is crucial for early detection of potential health concerns. Identifying issues early allows for more effective planning and customized treatment options.”
According to the American Cancer Society, around 43,250 women may succumb to breast cancer. Early diagnosis is vital in treating the disease effectively; very early-stage cases have a 97-100% chance of being cured.
PINK Breast Center offers state-of-the-art AI-powered 3D mammography technology to ensure the most accurate early diagnosis for women.
“Our skilled team and cutting-edge equipment set us apart,” Santos-Lima said while emphasizing community outreach aspects of their current awareness campaign, particularly in underprivileged communities. “Healthcare involves community engagement. Since not everyone has insurance coverage, spreading awareness about mammograms, preventive care, and early detection is crucial.”
PINK Breast Care employs INFINITT mammo PACS; a comprehensive mammography viewing solutions for full-field digital mammography, breast MRI, ultrasound, and other critical images. INFINITT Mammo PACS provides fast image loading and customizable viewing tools for full-field digital mammography, breast MRI, ultrasound, and other digital images on a single workstation. It allows for individual or group presets and features a protocol loop sequence for tailored viewing—while Digital Breast Tomosynthesis delivers three-dimensional images for more accurate screening or diagnoses. Mammo Tracking MQSA can seamlessly integrate with easy activation as an add-on module.
Other benefits include:
Integrates with Tomosynthesis manufacturers and automatically aligns current exam with priors.
Accelerates image loading for volume reading and remote viewing.
Improves abnormality detection with 2D CAD overlays.
Saves annotations and key images.
INFINITT North America and PINK Breast Care look forward to a brighter future, working together towards early detection and better patient outcomes.
The New Investigator Award is a highly competitive award that recognizes meritorious research conducted by an individual who is within 10 years of the completion of academic and professional training. The award was announced during ASRM’s Opening Ceremony on Monday, October 16, 2023 and presented during the ASRM Research Symposium on Wednesday, October 18, 2023.
“Dr. Devine has displayed a consistent and highly successful track record as a clinician-scientist performing and publishing important research that has significantly impacted the practice of reproductive endocrinology,” shares Michael A. Thomas, M.D., ASRM President.
“Dr. Devine defines the combination of clinician and researcher who devotes themselves to research to carry the field of reproductive medicine forward, allowing us to provide better care for our patients, and make a difference in the lives of so many,” shared Joseph Doyle, M.D., SGF physician, and Robert J. Stillman, M.D., SGF Medical Director Emeritus, in a letter of support for the award.
Dr. Devine is a board-certified reproductive endocrinologist who sees patients at SGF’s Washington, D.C., K Street location. She serves as Associate Program Director to fellows at the National Institutes of Health (NIH) who are training to become reproductive endocrinologists and to residents training to become obstetricians/gynecologists at Georgetown School of Medicine and GW School of Medicine, where she serves as Clinical Professor. Dr. Devine also serves as the Medical Director and Chief Research Officer at US Fertility, Chair of the Society for Reproductive Endocrinology and Infertility (SREI) Research Committee, and Chair of the Society for Assisted Reproductive Technology (SART) Quality Assurance Committee.
Learn more about US Fertility’s Research Division, which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.
About US Fertility
US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, along with Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. To date, US Fertility and Ovation Fertility practices have helped more than 225,000 individuals and couples build their families using assisted reproductive technology. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and by providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. Together with a growing suite of life science services, US Fertility is expanding access to the highest quality reproductive health care across over 100 clinic locations and 32 IVF laboratories. Visit http://www.USFertility.com for more information.
A total of 46 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2023 “Top Doctors” issue, representing 26 separate specialties, ranging from orthopedic surgery to pain management.
BALTIMORE, Md., Oct. 18, 2023 /PRNewswire-PRWeb/ — A total of 46 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2023 “Top Doctors” issue, representing 26 separate specialties, ranging from orthopedic surgery to pain management, specifically:
2023 – MERCY MEDICAL CENTER TOP DOCTORS – BALTIMORE MAGAZINE
1. Dr. Carlos Ince, Cardiology – Non-Interventional 2. Dr. Frederick Kuhn, Cardiology – Non-Interventional 3. Dr. Kevin Audlin, Gynecology – General 4. Dr. Lindsay Appel, Gynecology – OB-GYN 5. Dr. Mahwish Ali, Hospitalist Medicine 6. Dr. Kelli Eimer, Intensivist / Critical Care 7. Dr. David Sill, Interventional Radiology 8. Dr. Bonnie Gerecke, Neurology – Neuromusclar 9. Dr. Sandy Kotiah, Oncology General 10. Dr. Peter Ledakis, Oncology General 11. Dr. Dwight Im, Oncology – Gynecologic 12. Dr. Debashish Bose, Oncology – Surgical 13. Dr. Kurtis Campbell, Oncology – Surgical 14. Dr. Vadim Gushchin, Oncology – Surgical 15. Dr. John Campbell, Orthopedic Surgery – Foot & Ankle 16. Dr. Clifford Jeng, Orthopedic Surgery – Foot & Ankle 17. Dr. Rebecca Cerrato, Orthopedic Surgery – Foot & Ankle 18. Dr. Clayton Alexander, Orthopedic Surgery – Hand 19. Dr. Joseph Ciotola, Orthopedic Surgery – Joint 20. Dr. Marc Hungerford, Orthopedic Surgery – Joint 21. Dr. Kamala Littleton, Orthopedic Surgery – Joint 22. Dr. Mark Slabaugh, Orthopedic Surgery – Sports Medicine 23. Dr. Gregory Gasbarro, Orthopedic Surgery – Shoulder 24. Dr. David Maine, Pain Management 25. Dr. William Raoofi, Pain Management 26. Dr. Nicholas Anastasio, Physical Medicine/Rehabilitation 27. Dr. Sadia Khan, Rheumatology & Clinical Immunology 28. Dr. Lynn Ludmer, Rheumatology & Clinical Immunology 29. Dr. Neil Friedman, Surgery – Breast 30. Dr. Jennifer Joh, Surgery – Breast 31. Dr. Kelly Alexander, Surgery – General 32. Dr. J. Lawrence Fitzpatrick, Surgery – General 33. Dr. Nora Meenaghan, Surgery – General 34. Dr. Thomas Swope, Surgery – General 35. Dr. Brendan Collins, Surgery – Reconstructive 36. Dr. Charles Edwards II, Surgery – Spine 37. Dr. Adam Schell, Surgery – Spine 38. Dr. Paul Lucas, Surgery – Vascular 39. Dr. Vincent Noori, Surgery – Vascular 40. Dr. Richard (Mark) Ellerkmann, Urogynecology 41. Dr. Chelsea Goodier, Pediatrics – General 42. Dr. Michele Jules-Chapman, Pediatrics – General 43. Dr. Dawan King, Pediatrics – General 44. Dr. Michelle Williams, Pediatrics – General 45. Dr. Ashanti Woods, Pediatric – General 46. Dr. Michael Zimring, Travel Medicine
Each Mercy physician was recognized as among the best in the region in their respective fields.
Assisting in the Baltimore magazine “Top Docs” survey were four physician advisors, including Dr. Jennifer Taylor, OB/GYN, of Mercy’s Family Childbirth and Children’s Center, who provided professional expertise. Dr. Taylor has served on the advisory board for the past four years (2020, 2021, 2022, 2023). Board Certified in Obstetrics and Gynecology, Dr. Taylor earned her medical degree at State University of New York at Buffalo. She completed her residency in OB-GYN at the University of Maryland School of Medicine.
Founded in 1874 by The Sisters of Mercy, Mercy is home to the acclaimed Weinberg Center for Women’s Health & Medicine and the $400+ million, 20-story Mary Catherine Bunting Center. A university-affiliated teaching hospital, Mercy is nationally recognized with Magnet status for nursing excellence and named by Healthgrades as one of America’s 100 Best Hospitals for Orthopedic Surgery. For more information about Mercy, visit http://www.mdmercy.com, MDMercyMedia on Facebook and Twitter(X), @MDMercy on Youtube, or call 1-800-M.D.-Mercy.
Dr. James B. Wisner received his D.M.D. degree from the Medical University of South Carolina’s College of Dental Medicine. Dr. Wisner served in the United States Air Force where he completed an AEGD residency and was certified in intravenous conscious sedation. Dr. Wisner is an active member of the American Academy of Facial Esthetics (AAFE) and The Academy of Dental Sleep Medicine (AADSM), as well as the American Dental Association (ADA) and South Carolina Dental Association (SCDA). He has completed advanced training in implant surgery, adult orthodontics, Botox and facial aesthetics, CEREC crowns, 3D CBCT imaging, and cosmetic dentistry. Dr. Caitlin McPherson earned her Doctorate of Dental Medicine from the Medical University of South Carolina’s College of Dental Medicine. She is an active member of The American Dental Association and The Academy of General Dentistry. Dr. McPherson performs all aspects of general dentistry and is Invisalign certified, and she especially enjoys treating pediatric patients. Dr. Luke E. Severance received his Doctorate of Dental Medicine from the Medical University of South Carolina and attended a general practice residency in Columbia, SC. At Prisma Health Richland Hospital in Columbia, he extended his knowledge and expertise in various areas from IV moderate sedation, implant surgery, CEREC crowns, digital dentistry, pediatric dentistry, cosmetic dentistry and extractions. Peninsula Cosmetic & Family Dentistry is located at 538 Savannah Hwy in Charleston, SC. For more information or to schedule an appointment, please call (843) 507-5481 or visit http://www.peninsuladentistry.net.
Downlights by Certolux are engineered to meet the needs of surgical suites, patient rooms and behavioral health MELVILLE, N.Y., Oct. 18, 2023 /PRNewswire/ — Today, Leviton introduces three new series of sealed healthcare luminaires from Certolux. These specification-grade downlights are…
What is an FSA and an HSA? These tax-advantaged accounts allow users to set aside pre-tax income to pay for eligible healthcare and everyday wellness expenses (as determined by the Internal Revenue Service). Contributions reduce the account holder’s taxable income and withdrawals are not taxed, if funds are used for qualified expenses.
How do I enroll? An FSA can only be opened through an employer during the benefits enrollment period or if there is a qualifying event to allow a mid-year election. Any money contributed to the FSA remains with the employer in the event that an employee leaves their job for any reason (with the exception of any COBRA extension, if applicable). An HSA, on the other hand, can be opened at any time either through an employer’s benefit program or individually through an HSA administrator, as long as the person or family covered by the account is enrolled in a qualified high-deductible health plan (HDHP). An HSA is an employee-owned account that always belongs to the individual and the money in the account accrues tax-free over time and can be used to pay for qualified expenses in retirement.
What are the contribution limits? Both employees and employers can contribute to an FSA or an HSA. Employee FSA contributions are made with pre-tax payroll contributions, but employers can also make post-tax contributions to the employee FSA. The total FSA contribution amount for the year is available from day one. HSA contributions are also considered tax free, but they can be made via automatic payroll contributions or via post-tax contributions throughout the year that can be taken as an above-the-line deduction at tax time. For 2024, HSA contribution maximums will increase to an all-time high of $4,150 for individual coverage in a qualified HDHP, and $8,300 for two-person or family coverage. The total amount of employer and employee contributions cannot surpass this amount. While 2024 FSA limits have not yet been announced, Mercer is predicting a more than 5% increase to $3,200.
Is there a spending deadline? An FSA has an annual spending deadline or a time by which the balance must be spent or remaining funds are lost. This is called a forfeiture. For most people, the FSA deadline is Dec. 31 each year; however, this deadline can vary based on an organization’s plan year. An employer may also offer an FSA deadline extension, such as a partial rollover of unused funds, a grace period (2.5 months after your plan year end date; typically March 15), and/or a run-out period. To help account holders avoid potential FSA forfeitures, FSA Store offers free FSA Deadline Alerts that remind consumers when their personal deadline is approaching. This helps to ensure they won’t lose FSA funds.
How can FSA and HSA funds be used? The list of qualified expenses for FSAs and HSAs goes well beyond doctor visits and copays. Thanks in part to advocacy efforts from Health-E Commerce and other industry leaders, eligibility has continued to expand to include everyday items like over-the-counter medications, contacts and eyeglasses, hearing aids, menstrual care products, drug-free pain relief, and even high-tech health monitoring and diagnostic devices. It’s important to review a comprehensive FSA and HSA eligibility list to understand how these tax-free funds can be used in conjunction with health plan coverage to maximize the health, wellness, and financial wellbeing for individuals and families throughout the coming year.
How much can I save? Both FSAs and HSAs can help users save an estimated 30% (or $30 on every $100) on eligible healthcare expenses, depending on an individual’s tax bracket. A key differentiator is that HSAs allow users to invest a portion of those contributions into stocks, bonds, and mutual funds for retirement. HSAs also offer a unique triple tax advantage — contributions are tax-free (either through payroll deduction or as an above-the-line deduction at tax time), interest grows tax-free, and distributions for qualified healthcare expenses are also tax-free. To help individuals plan their contributions and estimate their savings potential, Health-E Commerce offers a free FSA calculator, along with HSA calculators that illustrate tax savings potential and future value of the account. Consumers who are considering an HSA for next year, can use the free HSA My Way tool at HSA Store to explore the different ways an HSA can be used to support their lifestyle and wellness needs.
For additional information and tools, visit the HSA Store or FSA Store Learning Centers.
About Health-E Commerce Health-E Commerce is the parent brand to FSA Store, HSA Store and WellDeservedHealth, a family of online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts. The company also created Caring Mill, a popular private-label line of health products that benefits Children’s Health Fund and enables customers to make a donation with each purchase. Since 2010, the Health-E Commerce brands have led the direct-to-consumer e-commerce market for exclusively pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding product eligibility for important new categories within the list of eligible medical expenses.
Hinton’s impressive career spans more than three decades, with a notable 21-year term as the President and CEO of Presbyterian Healthcare Services, New Mexico’s largest healthcare provider, before joining Baylor Scott & White Health. In 2014, he chaired the Board of Trustees of the American Hospital Association, a prominent advocacy and public policy organization representing nearly 5,000 hospitals and healthcare providers.
“Jim Hinton’s remarkable vision about healthcare is a tremendous asset for Kontakt.io,” commented Philipp von Gilsa, CEO of Kontakt.io. “With his guidance and profound industry experience, we are poised to extend our reach to health systems and make a significant impact on staff and patients through digital transformation.”
“The opportunity to advise Kontakt.io was an amazing fit for my professional mission to make healthcare better,” said Jim Hinton. “This company is genuinely committed to improving operational efficiency, reducing the burden on nurses and other staff, and enabling patient-centered care. Its leadership team is highly competent, dedicated to their commitments, and operates with impeccable ethics.”
For more information about Kontakt.io’s healthcare solutions, please visit kontakt.io/solutions-healthcare.
About Kontakt.io
Kontakt.io is a leader in Inpatient Journey Analytics. By understanding how patients and equipment move through the care delivery process, we uncover waste, optimize workflows, streamline capacity, and help your staff and patients feel seen and valued. Using AI, IoT, and RTLS, we enable responsive health systems that anticipate and adapt to constantly changing operational and human needs. Since 2013, Kontakt.io has provided solutions to +32,000 end users, delivered via +1,200 partners, and deployed +4 million IoT devices in the field.
Dr. Cody Cowen has been taking excellent care of his patients for over 15 years and counting. Dr Cowen earned his dental degree from LSU’s School of Dentistry. He has always enjoyed living in the Bayou State. practiced in his hometown of Shreveport for twelve years before returning to his tiger roots. He believes that your smile is the most influential feature you have. For this reason, he is dedicated to keeping teeth healthy, bright and pain-free. Dr. Jared Eades graduated from LSU’s School of Dentistry. Dr. Eades is dedicated to providing his community with high-quality dental care and looks forward to building long-lasting relationships with his patients. Southern Oaks Family Dental Care is located at 8670 Airline Hwy, Suite A in Baton Rouge, LA. For more information, please call 225-307-3275 or visit http://www.southernoaksfamilydental.com.
Breast reconstruction is shown to improve patients’ psychological, social and sexual well-being along with improving their quality of life following a mastectomy or lumpectomy. Patients deserve full and accurate information; empowering them to make the best decisions for their bodies. BRA Day promotes educating patients on the full range of options available to them so they can reclaim their bodies in a way that best supports their goals.
“The objective is to get patients who are adjusting to a new body comfortable again in their clothes and skin in a way that best serves them,” said Dr. Howard Levinson, MD, president of The PSF. “The significance of BRA Day is to make sure patients have both awareness and access to all their options to make the most well-informed choice that serves their unique needs.”
BRA Day is a movement that seeks to reduce obstacles in public education, patient care and research. BRA Day events worldwide bring attention to the varied options and procedures available and provides information to patients and their supporters so they can make informed decisions about their care. BRA Day efforts involve informing patients, family, caregivers, and media that the breast cancer loop remains open until a woman is informed of breast reconstruction options. BRA Day events are happening throughout the United States on Oct. 18 to raise money to support research and grants. ASPS and The PSF launched the Breast Reconstruction Awareness Campaign and the annual BRA Day USA in 2012. The inaugural BRA Day started in Canada in 2011.
The BRA Campaign has raised approximately $115,552 this year through the support of Diamond sponsor Allergan Aesthetics, an AbbVie company, campaign sponsors CareCredit and Integra Foundation and the many regional and local events. These contributions to the National BRA Fund support vital research, charitable giving and awareness grants.
The movement doesn’t end there. Other fundraising efforts include the CareCredit donation program. CareCredit will donate $1 to the Breast Reconstruction Awareness campaign every time a CareCredit cardholder purchases $200 or more on their card with an ASPS-member surgeon in the CareCredit network during October.
Capping off the month of awareness and support, the Breast Reconstruction Awareness 5K will take place on Saturday, Oct. 28, at 7:00 a.m. in Brush Square Park in Austin, TX, during Plastic Surgery The Meeting 2023. Participants can choose to run in person, virtually or show their support with literally no sweat by fundraising. Learn more and sign up at: https://www.plasticsurgerythemeeting.com/events.
About Breast Reconstruction Studies show that women who undergo breast reconstruction experience significant improvements in psychological, social and sexual well-being. Every patient deserves to learn about the full complement of breast reconstruction options at the time of diagnosis. In fact, the two main reasons women do not undergo breast reconstruction are because they are not referred to plastic surgeons and are not informed of their reconstructive options. Breast reconstruction is part of a comprehensive approach and treatment for breast cancer patients.
Integral to this cohesive team approach, are frequent meetings that occur to discuss each patient and her individualized treatment plan. Members of this group of specialists are oncologist, radiologists, plastic surgeons, breast surgeons, plastic pathologists, radiation oncologists, geneticists, nurses, patient care coordinators and more. Their collective insights guarantee that patients are not only aware of but also have access to a full range of reconstructive procedures, with decisions based on consensus among the team and ultimately the patient.
“Women need choices – they should be presented with the complete range of breast reconstruction options,” said Lynn Damitz, MD, ASPS Board Vice President of Health Policy & Advocacy. “Shared decision-making is the optimal goal where we are all part of the decision.”
For more information on breast reconstruction, visit http://www.breastreconusa.org. Become educated and help educate others about the availability of and access to breast reconstruction and why all women deserve a team approach to breast cancer treatment.
About ASPS The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing nearly 8,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About The PSF The Plastic Surgery Foundation (The PSF), founded in 1948, supports research, international volunteer programs and visiting professor programs. The foundation’s mission is to improve the quality of life of patients through research and development. The PSF accomplishes its mission by providing invaluable support to the research of plastic surgery sciences through a variety of grant programs. The PSF works in concert with the American Society of Plastic Surgeons (ASPS).
Plain language summaries, a regulatory requirement elsewhere in the world, are meant to provide the public with the results of a clinical trial in a way that is more easily understood (i.e., 6th-8th grade reading level). While still voluntary in the United States, there has been increased public outcry for transparency in the pharmaceutical industry and these plain language summary documents are required in the European Union (EU) under the EU Clinical Trial Regulation No. 536/2014.
This comes at a time when just 12 percent of Americans are considered proficient in their health literacy, according to the National Assessment of Adult Literacy, and most recent research out of the NIH shows that only about 14 percent of plain language summaries are available to clinical trial participants.
How does this help patient engagement?
“These health literacy numbers need to improve, and one way forward is to share information in formats that are accessible. AI-led technology like TrialAssure LINK will help the medical community, including researchers in biopharma, to more clearly communicate with participants and their families as to the results of the clinical trials and also increase treatment options. This initiative recognizes the importance of our collaboration, especially during Health Literacy Month this October,” said Prasad M. Koppolu, Chief Operating Officer, TrialAssure.
Koppolu continued, “By using TrialResults.com, we have charged past the lack of a current mandate for reporting these plain language summary documents and taken a step forward, posting understandable clinical trial results to help improve health literacy and give the entire pharmaceutical industry an opportunity to be more transparent.”
Plain language summaries help patients, their families, and the public at large by:
providing a better understanding of the clinical study that occurred,
giving more context and details around what the individual studies accomplished, or didn’t accomplish, and
helping them understand the value of personal contributions to science and empowering clinical trial participants to continue to be involved in clinical trials in the future.
On the TrialResults.com website, the public can learn about specific clinical trials for diseases or conditions of interest. Reading one of the approximately 50,000 plain language summaries available provides a starting point to understand the clinical trial at a high level – just enter a disease, condition, or study number in the search bar. The study sponsor will always be listed in the summary, making it easy for individuals to find direct and additional information on the sponsor website.
The plain language summary documents will be released on TrialResults.com in the following five groupings by condition and/or disease:
Oncology (available now)
Metabolic
Mental Health and Neurological
Respiratory
All others
To be notified when additional summaries are posted, email [email protected] to be added to the mailing list.
Reviewing the ClinicalTrials.gov record for further supporting data and understanding is recommended and a link will be available on TrialResults.com for each record. It should be emphasized that a physician should be consulted before making any healthcare decisions.
Saving one million hours by using AI to create 50,000 plain language summaries
“Three factors are converging in 2023 – the rise of public-facing generative AI technology, a resurgence in transparency initiatives with global health authorities, and mounting concerns related to health literacy despite major technological and scientific advances in recent decades,” said Zach Weingarden, Director of Product Solutions, TrialAssure.
Weingarden continues, “Plain language summary documents are notoriously time-consuming and can be challenging to write, and many pharmaceutical companies struggle to juggle resources between this and writing the required clinical study reports, completing other disclosure requirements, and filing their new drug applications. AI has the potential to turbocharge the initial drafting of these documents, automatically and in bulk, saving the skilled reviewers’ effort for a quick confirmation and finalization step. We have demonstrated this is possible by creating fully written drafts based solely upon data already available in public records.”
When manually drafting a plain language summary in the pharmaceutical industry, it takes approximately 20 hours per document to write from scratch. If this estimate is accurate, to draft 50,000 plain language summary documents would take approximately 1,000,000 hours. TrialAssure was able to reduce this workload to less than one day. Time, effort and cost no longer remain an excuse for transparency.
Accuracy of AI-generated plain language summary documents
“We hope this exercise will show that these AI-generated drafts are a great start, but AI has limited abilities and the use of AI is not a complete replacement of a skilled human writer,” said Weingarden. “Furthermore, we are limited to the data that is available in the ClinicalTrials.gov record. Depending on the structure and format of the data, it may be difficult for the AI to interpret and summarize accurately. We expect this to be an insightful demonstration of a committed path forward towards transparency, harvesting the scalable power and working to improve the limitations of our AI technology and welcome feedback from the scientific community.”
Feedback on the plain language summaries posted to TrialResults.com and generated by TrialAssure’s LINK application can be emailed to [email protected] and will help improve the quality of the plain language summaries.
With industry feedback incorporated and further Sponsor collaboration, TrialAssure will look to implement a new process in the near future that will use AI to automatically generate a plain language summary whenever a new record is available. This will scan ClinicalTrials.gov data daily, allowing new plain language summary documents to be available on TrialResults.com in near real-time.
TrialAssure, Inc. is a leading, global clinical trial disclosure and data transparency provider with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and intelligent software and service solutions to facilitate clinical trial disclosure (registration and results reporting), document and data anonymization, and enhanced patient engagement, while delivering the highest quality clinical trial transparency deliverables that exceed the most stringent requirements. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was named Data Solution of the Year – Healthcare in the Data Breakthrough Awards.
